UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-angiogenic Strategy in Cancer Therapy

Peltzer, N; Walczak, H; (2019) Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-angiogenic Strategy in Cancer Therapy. Developmental Cell , 48 (2) pp. 127-128. 10.1016/j.devcel.2019.01.011.

[img] Text
181228_Naito Preview.pdf - ["content_typename_Accepted version" not defined]
Access restricted to UCL open access staff until 29 January 2020.

Download (160kB)

Abstract

TAK1 is a key mediator of proinflammatory signals. In this issue of Developmental Cell, Naito et al. (2019) report that TAK1 loss from endothelial cells in adult mice results in intestinal and hepatic vascular destruction due to TNF-induced death of endothelial cells. Additionally, endothelial TAK1 deletion reduces tumor burden.

Type: Article
Title: Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-angiogenic Strategy in Cancer Therapy
Location: United States
DOI: 10.1016/j.devcel.2019.01.011
Publisher version: https://doi.org/10.1016/j.devcel.2019.01.011
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
URI: http://discovery.ucl.ac.uk/id/eprint/10067341
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item